Literature DB >> 8631027

Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.

T Ishiguro1, M Nakajima, M Naito, T Muto, T Tsuruo.   

Abstract

B16-F10 and B16-BL6 are B16 mouse melanoma sublines that preferentially metastasize to the lung following i.v. and s.c. injections, respectively. To study molecular mechanisms underlying the different metastatic behaviors exhibited by the B16 melanoma sublines, we performed differential hybridization of the genes transcribed in these cells and compared their expression levels. We isolated four genes that were highly expressed in B16-F10 cells but not in B16-BL6 cells: TI-225 (polyubiquitin), TI-229 (pyruvate kinase), TI-241 (LRF-1 homologue), and TI-227 (novel gene). Triosephosphate isomerase, 10-formyltetrahydrofolate dehydrogenase, tyrosinase-related protein 2, cytochrome c oxidase, ATP synthetase alpha subunit, RNA helicase, and ribosomal protein (L37, J1, acidic phosphoprotein), however, showed higher expression in B16-BL6 cells than in B16-F10 cells. Among these clones, transfection of TI-241 into the low metastatic clone F1 converted the parental cells from low- into high-metastatic cells. TI-241 may regulate the expression of various genes as a transcription factor in the complex process of metastasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631027

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

Review 2.  Phagosome maturation: aging gracefully.

Authors:  Otilia V Vieira; Roberto J Botelho; Sergio Grinstein
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

3.  Construction and selection of subtracted cDNA library of mouse hepatocarcinoma cell lines with different lymphatic metastasis potential.

Authors:  Li Hou; Jan-Wu Tang; Xiao-Nan Cui; Bo Wang; Bo Song; Lei Sun
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

4.  Subtractive screening of genes involved in cellular senescence.

Authors:  N Uehara; Y Katakura; T Miura; S Shirahata
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

5.  Activating transcription factor 3 promotes colon cancer metastasis.

Authors:  Zhi-Yong Wu; Zheng-Mao Wei; Sheng-Jie Sun; Jing Yuan; Shun-Chang Jiao
Journal:  Tumour Biol       Date:  2014-05-24

6.  Anti-cancer effects of enteric-coated polymers containing mistletoe lectin in murine melanoma cells in vitro and in vivo.

Authors:  Seung-Yeon Han; Chang-Eui Hong; Hwan-Gyu Kim; Su-Yun Lyu
Journal:  Mol Cell Biochem       Date:  2015-07-09       Impact factor: 3.396

7.  Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.

Authors:  T Ishiguro; M Naito; K Hanaoka; H Nagawa; T Muto; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

8.  Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.

Authors:  Kiyoshi Tamura; Bayin Hua; Susumu Adachi; Isil Guney; Junya Kawauchi; Masaki Morioka; Mimi Tamamori-Adachi; Yujiro Tanaka; Yusaku Nakabeppu; Makoto Sunamori; John M Sedivy; Shigetaka Kitajima
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

9.  The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.

Authors:  Saisai Wei; Hongbo Wang; Chunwan Lu; Sarah Malmut; Jianqiao Zhang; Shumei Ren; Guohua Yu; Wei Wang; Dale D Tang; Chunhong Yan
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

10.  Biological properties and gene expression associated with metastatic potential of human osteosarcoma.

Authors:  Tetsuhiro Nakano; Masachika Tani; Yasunori Ishibashi; Kenji Kimura; Yong-Bum Park; Natsuko Imaizumi; Hiroyuki Tsuda; Kazuhiko Aoyagi; Hiroki Sasaki; Susumu Ohwada; Jun Yokota
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.